Author

A. I. Chiramel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

S. M. Best· 2 shared A. A. Compton· 1 shared A. Kenney· 1 shared A. Zani· 1 shared B. Youseff· 1 shared C. Bosio· 1 shared F. Bouamr· 1 shared G. Shi· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

S. M. Best

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivApr 15, 2021

Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2

G. Shi, A. I. Chiramel, K. K. Lai…·A. A. Compton

This study shows rapalogs like rapamycin increase SARS-CoV-2 infection by reducing antiviral proteins through microautophagy, while ridaforolimus has less effect.

DOI 10.1172/jci160766

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivApr 11, 2019

TRIM5α restricts flavivirus replication by targeting the viral protease for proteasomal degradation.

A. I. Chiramel, N. Meyerson, K. McNally…·S. M. Best

This study shows TRIM5α restricts flavivirus replication by targeting the viral protease for proteasomal degradation, with implications for human susceptibility to emerging flaviviruses.

DOI 10.1016/j.celrep.2019.05.040

humanexperimental assay

𝕏 PostBluesky